Keyphrases
Erythropoietin
100%
Cognitive Effects
60%
Placebo-controlled Trial
50%
Affective Disorders
50%
Dorsal Medial Prefrontal Cortex
50%
Cognitive Impairment
50%
Prefrontal Cortex Activity
50%
Randomized Placebo-controlled Trial
50%
Electroconvulsive Therapy
50%
Major Depressive Disorder
20%
Bipolar Disorder
20%
Working Memory
20%
Functional Magnetic Resonance Imaging
18%
Episodic Memory
16%
EudraCT
14%
Cognitive Treatment
10%
Working Memory Task
10%
N-back
10%
Biomarker Model
10%
Cognitive Composite Scores
10%
Recent Changes
10%
Functional Outcome
10%
Neural Activity
10%
Procognitive
10%
Sustained Attention
10%
Manufacturing Process
10%
Treatment Change
10%
Saline Injection
10%
6-month Follow-up
10%
RhEPO
10%
Target Engagement
10%
Cognitive Outcome
10%
Parietal Cortex
8%
Global Cognition
8%
Memory Recall
8%
Neuroscience
Placebo
100%
Erythropoietin
100%
Cognitive Disorders
50%
Mood Disorder
50%
Prefrontal Cortex
50%
Electroconvulsive Therapy
50%
Working Memory
25%
Functional Magnetic Resonance Imaging
16%
Major Depressive Disorder
16%
Bipolar Disorder
16%
Autobiographical Memory
16%
Epileptic Absence
12%
Darbepoetin Alfa
8%
Cognitive Effect
8%
Parietal Cortex
8%
Psychology
Mood Disorder
50%
Prefrontal Cortex
50%
Electroconvulsive Therapy
50%
Cognitive Impairment
50%
Working Memory
25%
Functional Magnetic Resonance Imaging
16%
Autobiographical Memory
16%
Bipolar Disorder
16%
Depression
16%
Cognitive effects
8%
Sustained Attention
8%
Composite Score
8%
